These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31843588)

  • 1. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma.
    Barrau M; Maoui K; Le Roy B; Roblin X; Mismetti P; Phelip JM; Williet N
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3447-3454. PubMed ID: 33715087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC).
    González Caraballo I; Martín Lozano R; Jiménez Rodríguez R; Soto Alsar J; Ortega Morán L; Martín Jiménez M; Muñoz Martín AJ
    Clin Transl Oncol; 2024 Sep; 26(9):2388-2392. PubMed ID: 38558283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous Thromboembolism in Patients with Advanced Pancreatic Cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis.
    Jeong HT; Bae JH; Kim HG; Han J
    Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of venous thromboembolism in women with cervical cancer.
    Matsuo K; Moeini A; Machida H; Fullerton ME; Shabalova A; Brunette LL; Roman LD
    Gynecol Oncol; 2016 Sep; 142(3):405-12. PubMed ID: 27350404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
    Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study.
    Lee JC; Ro YS; Cho J; Park Y; Lee JH; Hwang JH; Choi HJ; Lee S
    Medicine (Baltimore); 2016 Apr; 95(17):e3472. PubMed ID: 27124043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.
    Mandalà M; Reni M; Cascinu S; Barni S; Floriani I; Cereda S; Berardi R; Mosconi S; Torri V; Labianca R
    Ann Oncol; 2007 Oct; 18(10):1660-5. PubMed ID: 17660490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous Thromboembolism in Japanese Patients With Pancreatic Cancer.
    Suzuki T; Hori R; Takeuchi K; Yamamura R; Katoh H; Noji Y; Yamaguchi M; Fujino S
    Clin Appl Thromb Hemost; 2021; 27():10760296211051766. PubMed ID: 34730013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.
    Singh I; Chou JF; Capanu M; Park J; Yu KH; Varghese AM; Park W; Zervoudakis A; Keane F; Rolston VS; Gerdes H; Wei AC; Shah P; Covey A; Schattner M; O'Reilly EM
    Pancreatology; 2024 Jun; 24(4):608-615. PubMed ID: 38749803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
    Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
    Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.
    Mohindroo C; Hasanov M; Rogers JE; Dong W; Prakash LR; Baydogan S; Mizrahi JD; Overman MJ; Varadhachary GR; Wolff RA; Javle MM; Fogelman DR; Lotze MT; Kim MP; Katz MHG; Pant S; Tzeng CD; McAllister F
    Cancer Med; 2021 Aug; 10(15):5041-5050. PubMed ID: 34250759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
    Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma.
    Baekelandt BM; Hjermstad MJ; Nordby T; Fagerland MW; Kure EH; Heiberg T; Buanes T; Labori KJ
    HPB (Oxford); 2016 Mar; 18(3):247-54. PubMed ID: 27017164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
    Poruk KE; Firpo MA; Huerter LM; Scaife CL; Emerson LL; Boucher KM; Jones KA; Mulvihill SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2605-10. PubMed ID: 20729288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.